← The SEC Ephemeris: the whole map
Almatica Pharma, LLC zolpidem tartrate
In the graph: all 1 documents (2 pages).
- Application
- NDA 215721
- Ticker
- Almatica Pharma, LLC
- Product
- zolpidem tartrate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- January 13, 2023
From FDA letters and SEC filings. Not investment or medical advice.